Bevacizumab plus temozolomide: a novel treatment option for advanced neuroendocrine tumors?
Anna
A
Koumarianou
Gregory
G
Kaltsas
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003606:Dacarbazine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D018358:Neuroendocrine Tumors / Q000188:drug therapy*
D003606:Dacarbazine